ArticleJournal of translational medicine2026
PFDN5 synergizes with anti-PD1 therapy to promote triple-negative breast cancer cell death through JAK2/STAT3/c-Myc signaling axis.
Xiao-Ren Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.